Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03329235Phase 1Completed
Phase 1, randomised, open-label trial of platelet-rich plasma in knee osteoarthritis (OA) (3 arms), sponsored by Cangzhou Central Hospital. Primary endpoint: Western Ontario and McMaster Universities Osteoarthritis Index at 18 months. Started Jan 2015; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03329235.